Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies

ANTONIO LOPEZ BELTRAN2026-01-292026-01-29201910.1080/14779072.2019.17046262-s2.0-85076889880https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/31157Cardiology and Cardiovascular MedicineInternal MedicineCardiology and Cardiovascular MedicineInternal MedicineTargeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studiesresearch article